Rowe JM - Search Results

1

Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII.

Kumar AJ, Gimotty PA, Gelfand JM, Buck G, Rowe JM, Goldstone AH, Fielding A, Marks DI, Litzow M, Paietta E, Lazarus HM, Tallman MS, Luger SM, Loren AW. Kumar AJ, et al. Among authors: rowe jm. Am J Hematol. 2016 Nov;91(11):1107-1112. doi: 10.1002/ajh.24497. Epub 2016 Aug 22. Am J Hematol. 2016. PMID: 27468137 Free PMC article. Clinical Trial.

2

Phase II study of mitoxantrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: a study of the Eastern Cooperative Oncology Group.

Dutcher JP, Eudey L, Wiernik PH, Paietta E, Bennett JM, Arlin Z, Kellermeyer R, Rowe J, O'Connell M, Oken M, et al. Dutcher JP, et al. Among authors: rowe j. Leukemia. 1992 Aug;6(8):770-5. Leukemia. 1992. PMID: 1379312 Clinical Trial.

3

Treatment of relapsed or refractory Hodgkin disease and non-Hodgkin lymphoma with high-dose chemoradiotherapy followed by unstimulated autologous peripheral stem cell rescue.

Rapoport AP, Rowe JM, Heal JM, Tanner MA, DiPersio JF. Rapoport AP, et al. Among authors: rowe jm. Am J Hematol. 1992 Jun;40(2):86-92. doi: 10.1002/ajh.2830400203. Am J Hematol. 1992. PMID: 1585923

4

Intravenous gammaglobulin treatment for immune thrombocytopenia associated with infectious mononucleosis.

Cyran EM, Rowe JM, Bloom RE. Cyran EM, et al. Among authors: rowe jm. Am J Hematol. 1991 Oct;38(2):124-9. doi: 10.1002/ajh.2830380210. Am J Hematol. 1991. PMID: 1951302

5

Low-dose cytosine arabinoside as remission induction therapy in refractory adult acute lymphocytic leukemia.

Onundarson PT, Rowe JM. Onundarson PT, et al. Among authors: rowe jm. Am J Med. 1989 Apr;86(4):493-4. doi: 10.1016/0002-9343(89)90357-4. Am J Med. 1989. PMID: 2929641 Free article. No abstract available.

6

Clinical use of hematopoietic growth factors in allogeneic bone marrow transplantation.

Lazarus HM, Rowe JM. Lazarus HM, et al. Among authors: rowe jm. Blood Rev. 1994 Sep;8(3):169-78. doi: 10.1016/0268-960x(94)90078-v. Blood Rev. 1994. PMID: 7529606 Review.

7

New and experimental therapies for treating graft-versus-host disease.

Lazarus HM, Rowe JM. Lazarus HM, et al. Among authors: rowe jm. Blood Rev. 1995 Jun;9(2):117-33. doi: 10.1016/s0268-960x(95)90031-4. Blood Rev. 1995. PMID: 7580389 Free article. Review. No abstract available.

8

Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience.

Tallman MS, Gray R, Bennett JM, Variakojis D, Robert N, Wood WC, Rowe JM, Wiernik PH. Tallman MS, et al. Among authors: rowe jm. J Clin Oncol. 1995 Jul;13(7):1557-63. doi: 10.1200/JCO.1995.13.7.1557. J Clin Oncol. 1995. PMID: 7602344 Clinical Trial.

9

Large granular lymphocyte leukemia presenting with both amegakaryocytic thrombocytopenic purpura and pure red cell aplasia: clinical course and response to immunosuppressive therapy.

Kouides PA, Rowe JM. Kouides PA, et al. Among authors: rowe jm. Am J Hematol. 1995 Jul;49(3):232-6. doi: 10.1002/ajh.2830490309. Am J Hematol. 1995. PMID: 7604815

10

A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490).

Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA, Oette D, Cassileth PA, Stadtmauer EA, Wiernik PH. Rowe JM, et al. Blood. 1995 Jul 15;86(2):457-62. Blood. 1995. PMID: 7605984 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

487 results

Search Page